Press Release: Insmed Incorporated Says IPLEX Shows Positive Results in Mid-Stage Trial - FierceBiotech

Press Release: Insmed Incorporated Says IPLEX Shows Positive Results in Mid-Stage Trial - FierceBiotech: "RICHMOND, Va. -- Insmed Inc., today announced positive results from a Phase II investigator-sponsored clinical study of the company's drug IPLEX(TM) in HIV-infected patients affected with HIV-associated Adipose Redistribution Syndrome (HARS)."